This federal contract award, valued at $3,258.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX Vaccine Oral Syringe 1.5ML, a critical medical product, to support military healthcare programs. The contract has an ultimate completion date of November 8, 2024 and is a firm fixed-price delivery order. There is no set-aside designation indicated, suggesting open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This award is likely a specific delivery order placed against the broader IDC, enabling efficient government procurement of essential medical commodities.
Generated 2/6/25, 9:04 AM